111 related articles for article (PubMed ID: 6208760)
21. Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5).
Trybulski EJ; Kramss RH; Mangano RM; Rusinko A
J Med Chem; 1990 Dec; 33(12):3190-8. PubMed ID: 2258905
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
Vickroy TW; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
[TBL] [Abstract][Full Text] [Related]
23. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
24. Muscarinic M2 receptors coupled to inhibition of adenylate cyclase in rat heart.
Wei JW; Wang MC
Chin J Physiol; 1990; 33(4):315-27. PubMed ID: 2129026
[TBL] [Abstract][Full Text] [Related]
25. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
Hu J; Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
[TBL] [Abstract][Full Text] [Related]
26. The regulation of muscarinic cholinergic receptors by guanine nucleotides in cardiac tissue.
Rosenberger LB; Roeske WR; Yamamura HI
Eur J Pharmacol; 1979 Jun; 56(1-2):179-80. PubMed ID: 467508
[No Abstract] [Full Text] [Related]
27. Evidence that reciprocal hindlimb scratching elicited in mice by intrathecal administration of muscarinic agonists is mediated through M1 type receptors.
Raffa RB; Mathiasen JR; Goode TL; Vaught JL
Life Sci; 1987 Oct; 41(15):1831-6. PubMed ID: 2443784
[TBL] [Abstract][Full Text] [Related]
28. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
Evans RA; Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
[TBL] [Abstract][Full Text] [Related]
29. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
Wang JX; Mei L; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
[TBL] [Abstract][Full Text] [Related]
30. Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1986 May; 237(2):577-82. PubMed ID: 3009794
[TBL] [Abstract][Full Text] [Related]
31. Ligand-binding properties of a muscarinic acetylcholine receptor from Torpedo electric organ.
Strange PG; Dowdall MJ; Golds PR; Pickard MR
FEBS Lett; 1980 Dec; 122(2):293-6. PubMed ID: 7202722
[No Abstract] [Full Text] [Related]
32. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
33. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
34. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
Nilvebrant L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
[TBL] [Abstract][Full Text] [Related]
35. Regulation of antagonist binding to cardiac muscarinic receptors.
Hosey MM
Biochem Biophys Res Commun; 1982 Jul; 107(1):314-21. PubMed ID: 6812577
[No Abstract] [Full Text] [Related]
36. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
[TBL] [Abstract][Full Text] [Related]
37. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.
Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M
Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141
[TBL] [Abstract][Full Text] [Related]
38. Obligatory role of a Tris/choline allosteric site in guanine nucleotide regulation of [3H]-L-QNB binding to muscarinic acetylcholine receptors.
Murphy KM; Sastre A
Biochem Biophys Res Commun; 1983 May; 113(1):280-5. PubMed ID: 6602611
[TBL] [Abstract][Full Text] [Related]
39. Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.
Giachetti A; Giraldo E; Ladinsky H; Montagna E
Br J Pharmacol; 1986 Sep; 89(1):83-90. PubMed ID: 2432979
[TBL] [Abstract][Full Text] [Related]
40. Guanine nucleotides modulate muscarinic receptor binding in the heart.
Berrie CP; Birdsall NJ; Burgen AS; Hulme EC
Biochem Biophys Res Commun; 1979 Apr; 87(4):1000-5. PubMed ID: 465020
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
